Tourette Syndrome

GPTKB entity

Statements (57)
Predicate Object
gptkbp:instance_of gptkb:disease
gptkbp:affects gptkb:children
employment opportunities
academic performance
gptkbp:can_be_misunderstood_as behavioral issues
conduct disorder
gptkbp:can_cause motor tics
vocal tics
gptkbp:can_lead_to social challenges
emotional difficulties
gptkbp:caused_by vaccines
gptkbp:characterized_by tics
gptkbp:diagnosis clinical evaluation
DSM-5 criteria
gptkbp:diseases gptkb:true
gptkbp:first_described_by 1885
gptkbp:genetic_factors_involved gptkb:true
https://www.w3.org/2000/01/rdf-schema#label Tourette Syndrome
gptkbp:impact quality of life
gptkbp:is_a mental illness
gptkbp:is_affected_by illness
fatigue
stress
gptkbp:is_associated_with ADHD
obsessive-compulsive disorder
gptkbp:is_common_in males
gptkbp:is_considered chronic condition
gptkbp:is_enhanced_by cognitive behavioral therapy
gptkbp:is_managed_by gptkb:psychotherapy
support groups
educational support
medication adjustments
gptkbp:is_often_accompanied_by echolalia
coprolalia
palilalia
gptkbp:is_often_seen_in gptkb:true
gptkbp:is_part_of tic disorders
gptkbp:is_recognized_by gptkb:World_Health_Organization
medical community
gptkbp:is_studied_in gptkb:psychology
neurology
psychiatry
gptkbp:is_subject_to stigma
gptkbp:named_after gptkb:Georges_Gilles_de_la_Tourette
gptkbp:neurotransmitters_involved norepinephrine
dopamine
serotonin
gptkbp:occurs_in anxiety disorders
learning disabilities
gptkbp:prevalence 0.3% to 0.9%
gptkbp:replaced_by gptkb:true
gptkbp:requires multidisciplinary approach
gptkbp:symptoms_may_improve_with adulthood
gptkbp:treatment gptkb:pharmaceuticals
gptkb:psychotherapy
gptkbp:bfsParent gptkb:Brad_Cohen
gptkbp:bfsLayer 7